Blog
23 Articles
![lab measuring tubes](https://letswinpc.org/wp-content/uploads/2024/04/measuring-tubes.jpg)
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.
![Dr. Elizabeth Jaffee](https://letswinpc.org/wp-content/uploads/2022/10/Elizabeth-Jaffee.jpg)
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
![AACR, Let's Win, Lustgarten logos](https://letswinpc.org/wp-content/uploads/2023/04/aacr-lw-lustgarten.png)
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.
![Lets Win PC logo](https://letswinpc.org/wp-content/uploads/2022/11/LetsWinPC-logo-720x480-2.gif)
ASCO 2023: Pancreatic Cancer Research Update
The pancreatic cancer research reports from ASCO 2023 focused on different chemotherapy combinations, including immunotherapy.
![latex gloved hand holding monoclonal antibodies vial](https://letswinpc.org/wp-content/uploads/2022/09/ct2022may2.jpg)
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
![Fractal flame ribbons in whte and red on a black background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020may15.jpg)
Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
![The tops of closed lab vials as seen from overhead against a blue-ish background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020mar26.jpg)
Combining Two Drugs with Different Approaches to Enhance Treatment
A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.
![computer rendering of DNA in Brown and blue against a black background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020mar2.jpg)
Testing the Safety of an Immunotherapy Combination After Surgery
A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.
![electron microscope image of concentric circles formed by reactive ion etching](https://letswinpc.org/wp-content/uploads/2022/09/ct2019mar29.jpg)
Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer
Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.
![A latex-gloved hand doing close lab work](https://letswinpc.org/wp-content/uploads/2022/09/ct2019mar5.jpg)
Targeting Cancer-Associated Wasting With Experimental Immunotherapy
Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.
![A human epithelial cell (DNA in blue) with increased numbers of centrosomes (green) amid a sea of normal cells.](https://letswinpc.org/wp-content/uploads/2022/09/ct2019jan14.jpg)
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
![Deirdre Cohen](https://letswinpc.org/wp-content/uploads/2022/10/Deirdre-Cohen.jpg)
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
![Clear flasks on a yellow background, filled with water colored blue, green, or red](https://letswinpc.org/wp-content/uploads/2022/09/ct2018nov6.jpg)
Immunotherapy Combination Plus Radiation for Pancreatic Cancer
Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.